Cancer Discovery

1.0k papers and 121.6k indexed citations i.

About

The 1.0k papers published in Cancer Discovery in the last decades have received a total of 121.6k indexed citations. Papers published in Cancer Discovery usually cover Molecular Biology (549 papers), Oncology (459 papers) and Cancer Research (281 papers) specifically the topics of Cancer Genomics and Diagnostics (177 papers), Cancer Immunotherapy and Biomarkers (102 papers) and Epigenetics and DNA Methylation (92 papers). The most active scholars publishing in Cancer Discovery are Douglas Hanahan, Nikolaus Schultz, Chris Sander, Ethan Cerami, Benjamin Groß, Uğur Doğrusöz, Erik Larsson, Michael Heuer, Jianjiong Gao and Bülent Arman Aksoy.

In The Last Decade

Fields of papers published in Cancer Discovery

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Cancer Discovery. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Cancer Discovery

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Cancer Discovery. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Cancer Discovery with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025